Indica vs Sativa vs Hybrid — differences in effects (table)
Indica vs Sativa vs hybrid: comparison, differences, and what to choose. Table from u Bucha.
If you've heard that indica relaxes and sativa stimulates — you've heard a simplification that breeders and sellers have cultivated since the 1970s. The reality is more complex. Genomic studies have shown that commercial "indicas" and "sativas" do not form distinct genetic clades — most commercially available strains are hybrids, and their effects depend more on the terpene profile and the THC to CBD ratio than on the botanical label (Piomelli & Russo, Trends in Plant Science, 2016). This article clarifies what truly distinguishes these categories, what is myth and what is fact, and compiles everything into a table.
KEY INFORMATION
• The indica/sativa division is a tradition of cultivators, not genomic science — modern research shows a lack of clear genetic clades (Piomelli & Russo, Trends in Plant Science, 2016).
• The effects of a strain primarily depend on the THC/CBD ratio and terpene profile — not on the indica/sativa label.
• Practically all commercial strains are hybrids — only landrace (wild strains) are genetically "pure."
• Myrcene, linalool, limonene, and pinene are the terpenes that have the greatest impact on modifying effects.
Where does the indica/sativa division come from and does it make sense?
Historically, Cannabis sativa was described by Carl Linnaeus in 1753 — it referred to industrial hemp grown in Europe. Cannabis indica was described by Jean-Baptiste Lamarck in 1785, studying plants brought from India — higher resin concentration, different leaf proportions. In the tradition of cannabis breeders, this division evolved towards descriptions of effects: indica = body high (relaxation, drowsiness, pain), sativa = head high (energy, creativity, euphoria).
The problem: decades of intensive crossing of strains have blurred these boundaries almost completely. Lynch and colleagues' genomic study from 2016 analyzed 81 cannabis strains — strains described as "indica" and "sativa" did not form coherent genetic groups. The correlation between the producer's label and the genome was weak (Lynch et al., PLOS ONE, 2016). In other words: the label on the package tells you how the breeder wanted to classify the strain — it doesn't tell you what is actually in it.
Piomelli and Russo in their 2016 review proposed replacing botanical classification with chemotypic classification — based on the THC:CBD ratio and dominant terpenes. This approach makes clinical and practical sense: instead of asking "indica or sativa?", we ask "what cannabinoid and terpene profile?"
Indica vs sativa vs hybrid — morphological and effect table
Despite scientific reservations about the indica/sativa dichotomy, the traditional division describes real morphological differences between plants and cultural expectations regarding effects. The table below compares traditional features with what science confirms or challenges.
| Feature | Indica (tradition) | Sativa (tradition) | Hybrid |
|---|---|---|---|
| Plant shape | Short, bushy, broad leaf | Tall, slender, narrow leaf | Intermediate or variable |
| Flowering time | 8–9 weeks | 10–16 weeks | Variable — depends on the strain |
| Traditional effects | Relaxation, sedation, body high | Energy, creativity, head high | Intermediate or balanced |
| Dominant terpenes (often) | Myrcene, linalool, beta-caryophyllene | Limonene, alpha-pinene, terpinolene | Depends on the crossbreeding |
| THC/CBD ratio (typically) | Variable; often higher THC | Variable; often lower CBD | Designed by the breeder |
| Genetic confirmation | Weak — lack of a clear lineage | Weak — lack of a clear lineage | Dominates the market |
| Examples of traditional strains | Afghan Kush, Hindu Kush | Durban Poison, Thai | OG Kush, Blue Dream, Gorilla Glue |
Data update: May 4, 2026
What really determines the effects of a strain?
If the indica/sativa/hybrid label is not a reliable predictor of effects, what is? Science points to three key factors.
1. THC to CBD ratio
THC (tetrahydrocannabinol) is a psychoactive cannabinoid that binds directly to CB1. Higher THC concentration = stronger psychoactive effect, higher risk of anxiety and paranoia in sensitive individuals. CBD modulates THC effects: it reduces unwanted psychotic and anxiety effects, and may prolong the duration of action by inhibiting THC metabolism. A strain with 25% THC and 0% CBD will behave differently than a strain with 20% THC / 4% CBD — regardless of the botanical label.
2. Terpene profile
Terpenes are aromatic compounds found in cannabis flowers — the same ones that give lavender, lemon, pine, and hops their scent. Over 150 terpenes have been discovered in cannabis. Key: myrcene (most often dominant) has sedative effects and enhances THC effects; limonene elevates mood and has potential anxiolytic properties; alpha-pinene improves mental clarity and may reduce short-term memory loss after THC; linalool is relaxing. Ethan Russo described the entourage effect phenomenon: terpenes modify the action of THC and CBD in a synergistic way (Russo, Frontiers in Plant Science, 2019).
3. User biology
Individual density of CB1 receptors (genetically determined), level of tolerance, gender, body weight, liver metabolism — all these factors influence how the same strain will affect different people. Therefore, one person may feel the "hint" of indica as highly sedating, while another may feel it as a light relaxation. Predicting effects based on the label is individually unreliable.
An interesting perspective is provided by the analysis of the CBD market: producers of hemp flower (containing less than 0.3% THC and high CBD) often describe their products in indica/sativa/hybrid terminology borrowed from the marijuana market. However, with THC concentrations so low that they do not produce psychoactive effects, this terminology loses most of its practical significance — the effects of CBD do not divide into "relaxing indica" and "energizing sativa" as clearly as with high THC. The only difference that may matter with CBD flower is the terpene profile affecting aroma and potential entourage effects.
Landrace — jedyne „czyste” odmiany
If you are interested in genetically "pure" indica or sativa, the answer lies in landrace strains — wild or traditional strains cultivated for centuries in geographical isolation without human crossing. Afghan landraces (Mazar-i-Sharif, Hindu Kush) are among the genetically purest indicas. African strains like Durban Poison or Malawi Gold are historical sativas. However, even landraces available today commercially are often somewhat crossed and differ from the original strains.
For practical purposes: if you are buying legal CBD flower in Poland, the label "sativa" or "indica" describes the morphology of the plant and the producer's expectations — it does not predict specific effects. More important information is the content of CBD, THC (max 0.3% for legal products), and the available CoA certificate with the terpene composition.
Hybrids in the CBD market — what producers describe as "sativa" or "indica"
In the legal CBD flower market in Poland and the EU, technical varieties of hemp (Cannabis sativa L.) prevail — however, producers and stores often describe individual batches of flower using the indica/sativa/hybrid terminology borrowed from the marijuana market. This is purely a marketing tactic, describing the morphology of the plant or traditional associations of breeders, not predicting effects with THC content below 0.3%.
A few practical observations from the CBD market: strains described as "sativa" usually have a slimmer, looser flower with dominant limonene or pinene terpenes — citrusy or piney aromas. "Indica" strains have denser flowers, often with earthy or fruity aromas (myrcene, linalool). Hybrids — a wide range of aromas. When purchasing CBD flower based on the indica/sativa label, focus on the aroma and terpene profile from the CoA — do not expect psychoactive differences as with high THC marijuana.
Entourage effect — why cannabinoids alone are not enough
Classic pharmacological studies focused on isolated compounds — isolated THC or CBD — and extrapolated the results to the action of the whole plant. The problem is that cannabis contains over 100 cannabinoids and more than 150 terpenes, which collectively interact with the endocannabinoid system and other receptors. Ethan Russo coined the term "entourage effect" to describe this synergistic action: the sum of cannabis components acts differently than each component alone (Russo, Frontiers in Plant Science, 2019).
In the context of the indica/sativa/hybrid debate, the entourage effect explains why two strains with identical THC/CBD profiles can act completely differently: it is the terpenes and minor cannabinoids that define the character of the experience. A strain with myrcene as the dominant terpene will have a different effect than a limonene strain — even with the same THC content. Therefore, the botanical label is secondary to the chemical profile of a specific batch of product.
Key terpenes and their effects
Myrcene — the most commonly dominant terpene in commercial strains. It has sedative properties and enhances the effects of THC by facilitating its passage through the blood-brain barrier. "Indica" strains statistically have higher concentrations of myrcene, which partially explains the association of indica with a relaxing effect.
Limonene — gives a lemony scent. Studies suggest anxiolytic and mood-enhancing properties. It dominates in many strains described as "sativa" or energizing hybrid (Russo, British Journal of Pharmacology, 2011).
Alpha-pinene — the scent of pine resin. It may limit short-term memory loss from THC by inhibiting the enzyme acetylcholinesterase. Present in strains associated with greater mental clarity alongside the effect of THC.
Linalool — lavender terpene. Anxiolytic and calming effects; may reduce activation of the nervous system caused by high doses of THC. Present in strains described as soothing anxiety.
Beta-caryophyllene — the only terpene that binds directly to the CB2 receptor (not CB1). Anti-inflammatory action. Dominates in strains with peppery and earthy aromas.
How to choose a strain — practical criteria for legal products
If you are looking for legal CBD flower in Poland, here is the hierarchy of information from most important to least important when choosing a product:
1. CBD and THC content (CoA certificate). A certificate of analysis from an independent laboratory is the only reliable information about what is actually in the product. The label may say "sativa" or "indica" — the CoA will tell you how much CBD, THC, CBG, and the most important terpenes are present. This is the starting point for an informed choice.
2. Terpene profile. If the CoA includes terpene analysis — that’s gold. Look for dominant terpenes and their ratios. Myrcene-dominant products will statistically be more relaxing; limonene ones — more mood-lifting; pinene ones — more clarifying.
3. Indica/sativa/hybrid label. Useful as a guideline from the producer describing the morphology of the plant and traditional associations. Do not treat it as a clinical prediction of effect.
4. Aroma and appearance. Terpenes create aroma — a strongly aromatic herb with a distinct lemon, pine, or pepper scent contains terpenes that have a real impact on the effect profile. Herb without aroma is herb with a limited terpene content — old or poorly stored.
It is also worth remembering that the experience with legal CBD flower fundamentally differs from the experience with recreational marijuana — the THC concentration is minimal (below 0.3%), and the effects of CBD are not psychoactive in the classical sense. Therefore, the association of "indica = couch, sativa = creativity" mainly pertains to the high THC market, not the CBD market. In the context of CBD flower, the labels sativa/indica/hybrid differ primarily in aroma and subtle terpene effects — not in intensity or character of action on the mind. When choosing a CBD product, focus on the CoA certificate and terpene profile, not just the botanical label from the producer. This is the only reliable and trustworthy way to make an informed choice among the dozens of strains available in the Polish legal cannabis product market in 2026.
Frequently Asked Questions
What is the difference in effects between indica and sativa?
Traditionally, indica is associated with a relaxing physical effect (sedation, drowsiness), while sativa is linked to an energizing mental effect (creativity, euphoria). However, modern science questions this dichotomy: commercial strains are practically exclusively hybrids, and effects depend more on terpenes and the THC/CBD ratio than on the label (Piomelli & Russo, Trends in Plant Science, 2016).
Are indica and sativa really separate species?
The taxonomy of cannabis is a subject of scientific dispute. Genomic studies have shown that commercial strains described as "indica" and "sativa" do not form distinct genetic clades (Lynch et al., PLOS ONE, 2016). Classification is based mainly on morphology and cultivation tradition, not on genomics.
What is a cannabis hybrid?
A hybrid is a variety obtained by crossing plants with indica and sativa traits. Practically all modern commercial strains are hybrids — exceptions are landrace (wild local strains). The division into "pure indica" or "sativa" is marketing, not botany.
What really determines the effects of a cannabis strain?
Three key factors: the ratio of THC to CBD (higher CBD modulates the psychoactive effects of THC), the terpene profile (myrcene = sedation, limonene = mood, pinene = mental clarity), and the individual biology of the user. The label "indica" or "sativa" is a cultural guideline, not a clinical prediction of effect.
Do terpenes really affect cannabis effects?
Yes — terpenes interact with the endocannabinoid system and other receptors. Myrcene has sedative effects, limonene lifts the mood, alpha-pinene improves memory and clarity, linalool relaxes. Russo described the entourage effect: terpenes modify the action of THC and CBD in a synergistic way (Russo, Frontiers in Plant Science, 2019).
This article is for informational and educational purposes and does not replace consultation with a doctor. If you are pregnant, breastfeeding, taking medications, or have chronic conditions, consult the use of supplements or herbs with a specialist.
Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04
